Document is current

Any future updates will be listed below

1334 AVA-ADR-001 supresses tumor growth and induces anti-tumor immunity by selectively inhibiting ADAR1 p150

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1334

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark